C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation-Reference-Cited by-同舟云学术

C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation

Published:2009-05 Issue:8 Volume:45 Page:1333-1351
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

De Mattia Elena,Toffoli Giuseppe

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference106 articles.

1. Methylenetetrahydrofolate reductase;Rosenblatt;Clin Invest Med,2001

2. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells;Bagley;Proc Natl Acad Sci USA,1998

3. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis;Brattstrom;Circulation,1998

4. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase;Frosst;Nat Genet,1995

5. Association of total plasma homocysteine with methylenetetrahydrofolate reductase genotypes 677C>T, 1298A>C, and 1793G>A and the corresponding haplotypes in Swedish children and adolescents;Bottiger;Int J Mol Med,2007

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diverse avenues of research support the transmethylation theory of psychosis: implications for neuroprotection;Exploration of Neuroprotective Therapy;2024-05-15

2. Association of the rs1801133 and rs1801131 polymorphisms in the MTHFR gene and the adverse drug reaction of methotrexate treatment in a sample of Iraqi rheumatoid arthritis patients;Pharmacia;2024-02-27

3. Sodium Butyrate Inhibits the Expression of Thymidylate Synthase and Induces Cell Death in Colorectal Cancer Cells;International Journal of Molecular Sciences;2024-01-26

4. Population Pharmacokinetic Model of Methotrexate in Brazilian Pediatric Patients with Acute Lymphoblastic Leukemia;Pharmaceutical Research;2023-06-08

5. Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?;Frontiers in Pharmacology;2023-05-15